---
figid: PMC8027060__fonc-11-602194-g001
figtitle: BRAF mutations promote the activation of this pathway and tumorigenesis
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8027060
filename: fonc-11-602194-g001.jpg
figlink: pmc/articles/PMC8027060/figure/f1/
number: F1
caption: BRAF mutations promote the activation of this pathway and tumorigenesis.
  The molecular-targeted drugs developed to date for BRAF-mutated CRC are shown alongside
  the cascade.
papertitle: 'Management of BRAF Gene Alterations in Metastatic Colorectal Cancer:
  From Current Therapeutic Strategies to Future Perspectives.'
reftext: Hiroyuki Takeda, et al. Front Oncol. 2021;11:602194.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9391345
figid_alias: PMC8027060__F1
figtype: Figure
redirect_from: /figures/PMC8027060__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8027060__fonc-11-602194-g001.html
  '@type': Dataset
  description: BRAF mutations promote the activation of this pathway and tumorigenesis.
    The molecular-targeted drugs developed to date for BRAF-mutated CRC are shown
    alongside the cascade.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Encorafenib
  - Vemurafenib
  - Dabrafenib
  - Binimetinib
  - Trametinib
---
